SCHEMBL20732919

SCHEMBL20732919

CN(C)c1ccc(-c2ccc3nccc(C(=O)N4CC[C@@H](O)C4)c3c2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 4/20 0.43
▸ GFER P55789 1/20 0.43
▸ CYP1A2 P05177 4/20 0.42
▸ CYP3A4 P08684 4/20 0.42
▸ LMNA P02545 3/20 0.42
▸ MAPK1 P28482 3/20 0.42
▸ CLK4 Q9HAZ1 3/20 0.42
▸ HSD17B10 Q99714 2/20 0.42
▸ USP2 O75604 2/20 0.42
▸ SLC22A12 Q96S37 4/20 0.42
▸ CYP2D6 P10635 2/20 0.41
▸ CYP2C19 P33261 2/20 0.41
▸ KDM4E B2RXH2 1/20 0.41
▸ MAPT P10636 1/20 0.41
▸ HPGD P15428 1/20 0.41
▸ MEN1 O00255 3/20 0.40
▸ ALDH1A1 P00352 2/20 0.40
▸ TP53 P04637 2/20 0.40
▸ CASP1 P29466 1/20 0.40
▸ CASP7 P55210 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20732855 1.00 KMT2A (0.43) KMT2AGFERCYP1A2CYP3A4LMNA
SCHEMBL22070420 1.00 KMT2A (0.43) KMT2AGFERCYP1A2CYP3A4LMNA
SCHEMBL20732861 0.88 CYP1A2 (0.42) KMT2ACYP1A2CYP3A4LMNAMAPK1
SCHEMBL22070421 0.88 CYP1A2 (0.42) KMT2ACYP1A2CYP3A4LMNAMAPK1
SCHEMBL20733063 0.88 CYP1A2 (0.42) KMT2ACYP1A2CYP3A4LMNAMAPK1
SCHEMBL22113889 0.85 CYP1A2 (0.45) KMT2AGFERCYP1A2CYP3A4LMNA
SCHEMBL20732852 0.79 LMNA (0.55) KMT2ACYP1A2CYP3A4LMNAMAPK1
SCHEMBL22113713 0.74 CYP1A2 (0.45) KMT2ACYP1A2CYP3A4LMNAMAPK1
SCHEMBL22070430 0.72 CCNC (0.42) LMNAHPGDALOX5APFEN1CCNC
SCHEMBL22119828 0.70 LMNA (0.53) KMT2ACYP1A2CYP3A4LMNAMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3666770-A1 NOVEL HETEROCYCLIC COMPOUNDS AS CDK8/19 INHIBITORS Joint Stock Company "Biocad" (RU) 2020-06-17 — — EP claimed
EP-3666770-A1 NOVEL HETEROCYCLIC COMPOUNDS AS CDK8/19 INHIBITORS Joint Stock Company "Biocad" (RU) 2020-06-17 — — EP disclosed
EP-3666770-A1 NOVEL HETEROCYCLIC COMPOUNDS AS CDK8/19 INHIBITORS Joint Stock Company "Biocad" (RU) 2020-06-17 — — EP disclosed
WO-2019031990-A1 NOVEL HETEROCYCLIC COMPOUNDS AS CDK8/19 INHIBITORS ЗАКРЫТОЕ АКЦИОНЕРНОЕ ОБЩЕСТВО "БИОКАД" 2019-02-14 — — WO disclosed
Send feedback